Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu-Reference-Cited by-同舟云学术

Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu

Published:1999-10 Issue:10 Volume:27 Page:1533-1541
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Cooley Sarah,Burns Linda J,Repka Tanya,Miller Jeffrey S

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference32 articles.

1. Cancer statistics, 1997;Parker;CA Cancer J Clin,1997

2. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America;Antman;J Clin Oncol,1997

3. Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer;Ayash;J Clin Oncol,1995

4. Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support [published erratum appears in Cancer 1994;74:773];Dunphy;Cancer,1994

5. Allogenic cell-mediated immunotherapy for breast cancer after autologous stem cell transplantation;Or;Cytokines Cell Mol Ther,1998

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2–Positive Advanced Gastric Cancer;JCO Precision Oncology;2024-05

2. Antibody dependent cell-mediated cytotoxicity selection pressure induces diverse mechanisms of resistance;Cancer Biology & Therapy;2023-10-25

3. Mechanisms of Resistance to Antibody-Drug Conjugates;International Journal of Molecular Sciences;2023-06-02

4. Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapies;Journal for ImmunoTherapy of Cancer;2023-06

5. Inhibiting N‐glycan processing increases the antibody binding affinity and effector function of human natural killer cells;Immunology;2023-05-22